Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNA2 | P20248 | 1/20 | 0.53 |
| ▸ | CDK2 | P24941 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 15/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 9/20 | 0.52 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7844428 | 1.00 | CCNA2 (0.53) | CCNA2CDK2PTGS2PTGS1CA1 | |
| SCHEMBL7845016 | 0.91 | PTGS2 (0.54) | CCNA2CDK2PTGS2PTGS1CA1 | |
| SCHEMBL7846445 | 0.91 | PTGS2 (0.52) | CCNA2CDK2PTGS2PTGS1CA1 | |
| SCHEMBL7844622 | 0.91 | PTGS2 (0.52) | CCNA2CDK2PTGS2PTGS1CA1 | |
| SCHEMBL7841215 | 0.91 | PTGS2 (0.54) | CCNA2CDK2PTGS2PTGS1CA1 | |
| SCHEMBL7843428 | 0.90 | PTGS2 (0.57) | CCNA2CDK2PTGS2PTGS1CA1 | |
| SCHEMBL7843800 | 0.90 | PTGS2 (0.52) | PTGS2PTGS1PTGDR2 | |
| SCHEMBL7843514 | 0.90 | PTGS2 (0.52) | PTGS2PTGS1PTGDR2 | |
| SCHEMBL7845608 | 0.90 | PTGS2 (0.57) | CCNA2CDK2PTGS2PTGS1CA1 | |
| SCHEMBL7841286 | 0.89 | PTGS2 (0.61) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1125932-A2 | Substituted thiazoles for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2001-08-22 | — | — | EP | disclosed |
| US-5668161-A | Substituted thiazoles for the treatment of inflammation | G.D. SEARLE & CO. (US) | 1997-09-16 | — | — | US | disclosed |
| EP-0772606-A1 | SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-05-14 | — | — | EP | disclosed |
| WO-1996003392-A1 | SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-02-08 | — | — | WO | disclosed |